Journal of Fluorine Chemistry, volume 131, issue 11, pages 1071-1081

Fluorine in health care: Organofluorine containing blockbuster drugs

Publication typeJournal Article
Publication date2010-11-01
Quartile SCImago
Q3
Quartile WOS
Q3
Impact factor1.9
ISSN00221139
Organic Chemistry
Biochemistry
Inorganic Chemistry
Physical and Theoretical Chemistry
Environmental Chemistry
Abstract
Organic fluorine compounds have had a profound impact on the development of bioactives for the modern pharmaceuticals market. It is estimated that up to 20% of pharmaceuticals prescribed or administered in the clinic contain a fluorine atom and 30% of the leading 30 blockbuster drugs by sales contain a fluorine. In this Highlight review, the top 10 fluorine containing pharmaceuticals (by US Sales in 2008) are highlighted. By this measure, these are currently the most significant fluorinated compounds impacting on health care. They embrace statins (Lipitor, Crestor, Vytorin, Zetia/Ezetimibe), anti-inflammatories (fluticasone propionate, Celebrex), antacids (Prevacid), antidepressants (Lexapro), neuroleptics (Risperdal) and antibiotics (Levaquin). In each case the structures and modes of action of these important drugs compounds are reviewed and representative synthetic routes are highlighted.

Top-30

Citations by journals

10
20
30
40
50
60
70
Journal of Fluorine Chemistry
62 publications, 8.33%
Journal of Organic Chemistry
49 publications, 6.59%
European Journal of Organic Chemistry
47 publications, 6.32%
Organic Letters
41 publications, 5.51%
Organic and Biomolecular Chemistry
39 publications, 5.24%
Angewandte Chemie
31 publications, 4.17%
Angewandte Chemie - International Edition
30 publications, 4.03%
Chemistry - A European Journal
29 publications, 3.9%
Tetrahedron
18 publications, 2.42%
Beilstein Journal of Organic Chemistry
17 publications, 2.28%
Advanced Synthesis and Catalysis
17 publications, 2.28%
Chemical Communications
17 publications, 2.28%
Tetrahedron Letters
14 publications, 1.88%
RSC Advances
12 publications, 1.61%
Organic Chemistry Frontiers
11 publications, 1.48%
Chemical Reviews
10 publications, 1.34%
Synthesis
10 publications, 1.34%
Russian Chemical Bulletin
9 publications, 1.21%
Molecules
9 publications, 1.21%
Chemical Record
8 publications, 1.08%
Asian Journal of Organic Chemistry
7 publications, 0.94%
Chemistry - An Asian Journal
7 publications, 0.94%
Organometallics
7 publications, 0.94%
Chemical Science
7 publications, 0.94%
Journal of the American Chemical Society
6 publications, 0.81%
ChemistrySelect
6 publications, 0.81%
Journal of Medicinal Chemistry
6 publications, 0.81%
ACS Catalysis
6 publications, 0.81%
Mendeleev Communications
5 publications, 0.67%
10
20
30
40
50
60
70

Citations by publishers

50
100
150
200
250
Wiley
214 publications, 28.76%
Elsevier
149 publications, 20.03%
American Chemical Society (ACS)
147 publications, 19.76%
Royal Society of Chemistry (RSC)
109 publications, 14.65%
Springer Nature
28 publications, 3.76%
Multidisciplinary Digital Publishing Institute (MDPI)
19 publications, 2.55%
Beilstein-Institut
17 publications, 2.28%
Thieme
15 publications, 2.02%
Taylor & Francis
10 publications, 1.34%
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
4 publications, 0.54%
Bentham Science
4 publications, 0.54%
Pleiades Publishing
4 publications, 0.54%
The Electrochemical Society
2 publications, 0.27%
Pharmaceutical Society of Japan
2 publications, 0.27%
Frontiers Media S.A.
2 publications, 0.27%
Walter de Gruyter
2 publications, 0.27%
American Institute of Physics (AIP)
2 publications, 0.27%
CSIRO Publishing
1 publication, 0.13%
International Union of Crystallography (IUCr)
1 publication, 0.13%
Society of Nuclear Medicine and Molecular Imaging
1 publication, 0.13%
American Association for the Advancement of Science (AAAS)
1 publication, 0.13%
Pesticide Science Society of Japan/Nippon Noyaku Gakkai
1 publication, 0.13%
Hindawi Limited
1 publication, 0.13%
OAE Publishing Inc.
1 publication, 0.13%
50
100
150
200
250
  • We do not take into account publications without a DOI.
  • Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
Share
Cite this
GOST |
Cite this
GOST Copy
O'Hagan D. Fluorine in health care: Organofluorine containing blockbuster drugs // Journal of Fluorine Chemistry. 2010. Vol. 131. No. 11. pp. 1071-1081.
GOST all authors (up to 50) Copy
O'Hagan D. Fluorine in health care: Organofluorine containing blockbuster drugs // Journal of Fluorine Chemistry. 2010. Vol. 131. No. 11. pp. 1071-1081.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1016/j.jfluchem.2010.03.003
UR - https://doi.org/10.1016/j.jfluchem.2010.03.003
TI - Fluorine in health care: Organofluorine containing blockbuster drugs
T2 - Journal of Fluorine Chemistry
AU - O'Hagan, David
PY - 2010
DA - 2010/11/01 00:00:00
PB - Elsevier
SP - 1071-1081
IS - 11
VL - 131
SN - 0022-1139
ER -
BibTex |
Cite this
BibTex Copy
@article{2010_O'Hagan,
author = {David O'Hagan},
title = {Fluorine in health care: Organofluorine containing blockbuster drugs},
journal = {Journal of Fluorine Chemistry},
year = {2010},
volume = {131},
publisher = {Elsevier},
month = {nov},
url = {https://doi.org/10.1016/j.jfluchem.2010.03.003},
number = {11},
pages = {1071--1081},
doi = {10.1016/j.jfluchem.2010.03.003}
}
MLA
Cite this
MLA Copy
O'Hagan, David. “Fluorine in health care: Organofluorine containing blockbuster drugs.” Journal of Fluorine Chemistry, vol. 131, no. 11, Nov. 2010, pp. 1071-1081. https://doi.org/10.1016/j.jfluchem.2010.03.003.
Found error?